-
公开(公告)号:US08541589B2
公开(公告)日:2013-09-24
申请号:US13857108
申请日:2013-04-04
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier
IPC分类号: A61K31/519 , C07D211/72
CPC分类号: C07D213/70 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/519 , A61K45/06 , C07D239/38 , C07D241/18 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D405/10 , C07D417/04 , C07D417/10
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
摘要翻译: 本文描述了可用于调节血液尿酸水平的化合物,含有它们的制剂和使用它们的方法。 在一些实施方案中,本文所述的化合物用于治疗或预防与尿酸异常水平相关的病症。
-
公开(公告)号:US10919858B2
公开(公告)日:2021-02-16
申请号:US16190925
申请日:2018-11-14
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier , Chixu Chen
IPC分类号: C07D213/70 , A61K31/497 , C07D403/10 , C07D405/10 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/519 , A61K31/502 , A61K31/505 , A61K31/506 , C07D417/10 , A61K45/06 , C07D401/10 , C07D417/04 , C07D405/04 , C07D403/04 , C07D401/04 , C07D241/18 , C07D239/38
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
-
公开(公告)号:US20130203779A1
公开(公告)日:2013-08-08
申请号:US13857108
申请日:2013-04-04
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier
IPC分类号: A61K31/4418 , A61K31/519 , A61K31/426 , C07D213/70
CPC分类号: C07D213/70 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/519 , A61K45/06 , C07D239/38 , C07D241/18 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D405/10 , C07D417/04 , C07D417/10
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
-
公开(公告)号:US20190185431A1
公开(公告)日:2019-06-20
申请号:US16190925
申请日:2018-11-14
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier , Chixu Chen
IPC分类号: C07D213/70 , A61K31/519 , C07D239/38 , C07D403/10 , C07D405/10 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , C07D417/10 , A61K45/06 , C07D417/04 , C07D405/04 , C07D403/04 , C07D401/04 , C07D241/18 , C07D401/10
CPC分类号: C07D213/70 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/519 , A61K45/06 , C07D239/38 , C07D241/18 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D405/10 , C07D417/04 , C07D417/10
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
-
公开(公告)号:US08629278B2
公开(公告)日:2014-01-14
申请号:US13913272
申请日:2013-06-07
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier
IPC分类号: C07D211/72 , A61K31/519
CPC分类号: C07D213/70 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/519 , A61K45/06 , C07D239/38 , C07D241/18 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D405/10 , C07D417/04 , C07D417/10
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
摘要翻译: 本文描述了可用于调节血液尿酸水平的化合物,含有它们的制剂和使用它们的方法。 在一些实施方案中,本文所述的化合物用于治疗或预防与尿酸异常水平相关的病症。
-
公开(公告)号:US20130281469A1
公开(公告)日:2013-10-24
申请号:US13913272
申请日:2013-06-07
发明人: Samedy Ouk , Esmir Gunic , Jean-Michel Vernier
IPC分类号: C07D213/70 , A61K31/519 , A61K31/426 , A61K31/4418
CPC分类号: C07D213/70 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/497 , A61K31/502 , A61K31/505 , A61K31/506 , A61K31/519 , A61K45/06 , C07D239/38 , C07D241/18 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D405/10 , C07D417/04 , C07D417/10
摘要: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
-
-
-
-
-